• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

呼吸道微生物组在成人 RSV 控制挑战研究中的弹性。

Resilience of the respiratory microbiome in controlled adult RSV challenge study.

机构信息

National Heart and Lung Institute, Imperial College London, London, UK.

Dept of Infectious Disease, Imperial College London, London, UK.

出版信息

Eur Respir J. 2021 Dec 31;59(1). doi: 10.1183/13993003.01932-2021. Print 2022 Jan.

DOI:10.1183/13993003.01932-2021
PMID:34711536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8754103/
Abstract

https://bit.ly/3AwnMc8

摘要

文献链接

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/8754103/c0b494d49496/ERJ-01932-2021.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/8754103/c0b494d49496/ERJ-01932-2021.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/8754103/c0b494d49496/ERJ-01932-2021.01.jpg

相似文献

1
Resilience of the respiratory microbiome in controlled adult RSV challenge study.呼吸道微生物组在成人 RSV 控制挑战研究中的弹性。
Eur Respir J. 2021 Dec 31;59(1). doi: 10.1183/13993003.01932-2021. Print 2022 Jan.
2
Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins.呈现呼吸道合胞病毒融合或附着糖蛋白的混合病毒样颗粒诱导的附加保护作用。
Antiviral Res. 2014 Nov;111:129-35. doi: 10.1016/j.antiviral.2014.09.005. Epub 2014 Sep 18.
3
Oral administration of rescues streptomycin-exacerbated respiratory syncytial virus-induced lung inflammation in mice.口服给予可挽救链霉素加剧的呼吸道合胞病毒诱导的肺部炎症反应。
Virulence. 2021 Dec;12(1):2133-2148. doi: 10.1080/21505594.2021.1962137.
4
Role of nasal microbiota and host response in infants with respiratory syncytial virus infection: Causal questions about respiratory outcomes.鼻微生物群和宿主反应在呼吸道合胞病毒感染婴儿中的作用：关于呼吸结局的因果问题。
J Allergy Clin Immunol. 2022 Mar;149(3):898-900. doi: 10.1016/j.jaci.2021.12.758. Epub 2021 Dec 11.
5
A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus.一种独特的联合佐剂调节免疫反应，可预防单次融合蛋白接种和呼吸道合胞病毒挑战后疫苗增强的肺部组织病理学。
Virology. 2019 Aug;534:1-13. doi: 10.1016/j.virol.2019.05.010. Epub 2019 May 28.
6
Development of a respiratory syncytial virus vaccine using human hepatitis B core-based virus-like particles to induce mucosal immunity.利用基于人乙型肝炎核心抗原的病毒样颗粒开发呼吸道合胞病毒疫苗以诱导黏膜免疫。
Vaccine. 2021 Jun 2;39(24):3259-3269. doi: 10.1016/j.vaccine.2021.04.038. Epub 2021 May 8.
7
Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment.经呼吸道合胞病毒G蛋白片段肠胃外免疫后，γ干扰素对小鼠上呼吸道的依赖性保护作用。
J Virol. 2002 Oct;76(20):10203-10. doi: 10.1128/jvi.76.20.10203-10210.2002.
8
Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice.壳聚糖改变了灭活呼吸道合胞病毒疫苗引起的免疫应答，而不影响小鼠肺部的组织病理学。
Vaccine. 2019 Jul 9;37(30):4031-4039. doi: 10.1016/j.vaccine.2019.06.003. Epub 2019 Jun 8.
9
Intranasal immunization with a helper-dependent adenoviral vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB/c mice.鼻腔内免疫接种表达人呼吸道合胞病毒优化密码子融合糖蛋白的辅助依赖性腺病毒载体可在 BALB/c 小鼠中引发保护性免疫。
Virol J. 2013 Jun 7;10:183. doi: 10.1186/1743-422X-10-183.
10
Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.含呼吸道合胞病毒 G 蛋白的新城疫病毒样颗粒在 BALB/c 小鼠中诱导产生保护作用，且无免疫病理学证据。
J Virol. 2010 Jan;84(2):1110-23. doi: 10.1128/JVI.01709-09. Epub 2009 Nov 4.

引用本文的文献

1
Post-viral lung diseases: the microbiota as a key player.病毒感染后肺部疾病：微生物群作为关键因素
ERJ Open Res. 2025 Apr 7;11(2). doi: 10.1183/23120541.00560-2024. eCollection 2025 Mar.
2
Severe respiratory syncytial virus disease.严重呼吸道合胞病毒疾病
J Intensive Med. 2024 Apr 20;4(4):405-416. doi: 10.1016/j.jointm.2024.03.001. eCollection 2024 Oct.
3
Microbiome in the nasopharynx: Insights into the impact of COVID-19 severity.鼻咽部微生物群：对新冠病毒疾病严重程度影响的见解

本文引用的文献

1
Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection.呼吸道黏膜中性粒细胞炎症使 RSV 感染易于发生。
Science. 2020 Oct 9;370(6513). doi: 10.1126/science.aba9301.
2
Microbiome-Transcriptome Interactions Related to Severity of Respiratory Syncytial Virus Infection.微生物组-转录组相互作用与呼吸道合胞病毒感染的严重程度相关。
Sci Rep. 2019 Sep 25;9(1):13824. doi: 10.1038/s41598-019-50217-w.
3
Respiratory syncytial virus (RSV): a scourge from infancy to old age.呼吸道合胞病毒（RSV）：从婴儿到老年的祸害。
Heliyon. 2024 May 18;10(10):e31562. doi: 10.1016/j.heliyon.2024.e31562. eCollection 2024 May 30.
4
Interactions of the bacteriome, virome, and immune system in the nose.鼻腔中细菌群落、病毒群落与免疫系统的相互作用。
FEMS Microbes. 2022 Aug 4;3:xtac020. doi: 10.1093/femsmc/xtac020. eCollection 2022.
5
Coccidioidomycosis and Host Microbiome Interactions: What We Know and What We Can Infer from Other Respiratory Infections.球孢子菌病与宿主微生物组相互作用：我们所知道的以及我们能从其他呼吸道感染中推断出的内容。
J Fungi (Basel). 2023 May 18;9(5):586. doi: 10.3390/jof9050586.
6
Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance.COVID-19 患者呼吸道微生物组的改变：当前观察结果及潜在意义。
Microbiome. 2022 Oct 5;10(1):165. doi: 10.1186/s40168-022-01342-8.
Thorax. 2019 Oct;74(10):986-993. doi: 10.1136/thoraxjnl-2018-212212. Epub 2019 Aug 5.
4
Ethical Criteria for Human Challenge Studies in Infectious Diseases.传染病人体激发试验的伦理标准。
Public Health Ethics. 2016 Apr;9(1):92-103. doi: 10.1093/phe/phv026. Epub 2015 Sep 27.
5
Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples.鼻腔和支气管分泌物的吸收：人体呼吸道黏膜的精准采样及样本的实验室处理
J Vis Exp. 2018 Jan 21(131):56413. doi: 10.3791/56413.
6
The impact of persistent bacterial bronchitis on the pulmonary microbiome of children.持续性细菌性支气管炎对儿童肺部微生物群的影响。
PLoS One. 2017 Dec 27;12(12):e0190075. doi: 10.1371/journal.pone.0190075. eCollection 2017.
7
Maturation of the Infant Respiratory Microbiota, Environmental Drivers, and Health Consequences. A Prospective Cohort Study.婴儿呼吸微生物组的成熟、环境驱动因素和健康后果。一项前瞻性队列研究。
Am J Respir Crit Care Med. 2017 Dec 15;196(12):1582-1590. doi: 10.1164/rccm.201703-0554OC.
8
The Influence of the Microbiome on Early-Life Severe Viral Lower Respiratory Infections and Asthma-Food for Thought?微生物群对生命早期严重病毒性下呼吸道感染和哮喘的影响——值得思考？
Front Immunol. 2017 Feb 16;8:156. doi: 10.3389/fimmu.2017.00156. eCollection 2017.
9
Nasopharyngeal Microbiome in Respiratory Syncytial Virus Resembles Profile Associated with Increased Childhood Asthma Risk.呼吸道合胞病毒感染时的鼻咽微生物群类似于与儿童哮喘风险增加相关的特征。
Am J Respir Crit Care Med. 2016 May 15;193(10):1180-3. doi: 10.1164/rccm.201512-2350LE.
10
Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection.呼吸道合胞病毒感染儿童的鼻咽微生物群、宿主转录组与疾病严重程度
Am J Respir Crit Care Med. 2016 Nov 1;194(9):1104-1115. doi: 10.1164/rccm.201602-0220OC.